The stem cell treatment provides a new source of healthy plasma cells. There are generally two types of transplant for multiple myeloma:
- Autologous stem cell transplant. It uses stems cells taken from a patient’s own blood.
- Allogeneic stem cell transplant. It involves stem cells from a donor. The risk of it is very high.
- If a patient has an identical twin, a syngeneic transplant in which the twin serve as donor is the best option.
Both allogeneic transplant and syngeneic transplant have the risk of graft-versus-host disease. That means donor’s immune cells regard the patient’s tissues as foreign and attack them. Graft-versus-host disease will not happen in autologous transplant because the donor tissue is provided by patients themselves. But autologous transplant may have other risks.
All stem cell treatments have their benefits and risks. Therefore, you must ask your doctor whether it is suitable for you. Multiple myeloma varies from people to people. Never choose a certain treatment merely based on your own decision.
Keywords: stem cell treatment multiple myeloma